For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211122:nRSV0304Ta&default-theme=true
RNS Number : 0304T Coral Products PLC 22 November 2021
CORAL PRODUCTS PLC
('Coral' or the 'Company' or the 'Group')
Completion of sale of property
Coral Products plc, a specialist in the design, manufacture and supply of
plastic products based in Wythenshawe, Manchester, is pleased to announce the
completion on 19 November 2021 for the sale of the Company's freehold premises
at North Florida Road Haydock, Merseyside to Glenbrook CP Limited for
approximately £3.5 million, as previously announced on 5 May 2021.
The net proceeds of £3.5 million have now been received, and will be used to
support organic growth whilst allowing the Company to seek acquisitions to
augment its existing activities and reward shareholders for their long term
support.
The profit on the sale of approximately £900,000 will be accounted for in our
full year results to 30 April 2022.
The Company will report free cash and cash equivalents as at 31 October 2021,
in its interims results, of approximately £5.5 million, this is before the
property proceeds.
ENQUIRIES:
Coral Products plc
Joe Grimmond, Executive
Chairman
Tel: 07703 518148
WH Ireland, Nominated Adviser and
Broker
Tel: 020 7220 1666
Adrian Hadden
Darshan Patel
Megan Liddell
Capital Markets Consultants
Limited
Tel: 07515 587184
Richard
Pearson
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DISEAXFNFEKFFFA